Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics

Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Nevertheless, the molecular mechanisms underlying the development of SCLC are unclear, requiring further investigation. The current research aims to identify relevant biomarkers and available drugs to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Zhou, Xiwen, Lyu, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560035/
https://www.ncbi.nlm.nih.gov/pubmed/37808164
http://dx.doi.org/10.1515/med-2023-0806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560035/
https://www.ncbi.nlm.nih.gov/pubmed/37808164
http://dx.doi.org/10.1515/med-2023-0806

Ejemplares similares